We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.

FOR PREVIEW ONLY (Print)

Stephan R. Targan, MD

Director, Inflammatory Bowel Disease Center

Director, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute

Feintech Family Chair in Inflammatory Bowel Disease

8730 Alden Drive
Los Angeles, CA 90048

Phone:

310-423-4100

Fax:

310-423-1486

Stephan R. Targan, MD

Director, Inflammatory Bowel Disease Center

Director, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute

Feintech Family Chair in Inflammatory Bowel Disease

  • IM/Gastroenterology

Blood in Stool

Colitis

Crohn's Disease

Esophageal Disorders

Gastrointestinal Disorders

Inflammatory Bowel Disease (IBD)

Rectal Bleeding

Ulcerative Colitis

Stephan Targan, MD, bases his translational and basic research programs on an integrated science paradigm. His programs focus primarily on immunopathologic mechanisms, novel therapeutics and the translation of basic science findings for use in diagnosis, prognosis and targeted therapeutic selection in inflammatory bowel disease. Human in vitro and animal model are used in genetic and immunobiologic investigations to elucidate the dysregulated immune responses in the gastrointestinal tract that lead to mucosal inflammation.

  • Medical School: Johns Hopkins Medical School, 1971
  • Residency: Harbor General Hospital, 1972
  • Residency: Harbor General Hospital, 1974
  • Residency: Harbor General Hospital, 1976
  • Fellowship: UCLA Medical Center, 1978
  • Associate Editor: Inflammatory Bowel Diseases, Current
  • Editorial Board: Clinical Gastroenterology and Hepatology, Current
  • Cedars-Sinai Pioneer in Medicine Award, 2014
  • Crohn's and Colitis Foundation of America Scientific Achievement Award, 2009
  • Feintech Family Chair in Inflammatory Bowel Disease, 1992
  • American Association of Physicians, 1998
  • American Society for Clinical Investigation, 1985
  • American Gastroenterological Association, 1979

Show moreShow less

Click here for a list of peer-reviewed publications.

  • Gonsky R, Deem RL, Landers CJ, Haritunians T, Yang S, Targan SR. IFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretion. Inflamm Bowel Dis. 2014;20(10):1794-1801.
  • Barrett R, Ornelas L, Yeager N, Mandefro B, Sahabian A, Lenaeus L, Targan SR, Svendsen CN, Sareen D. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines. Stem Cells Transl Med. 2014;3(12):1429-1434.

English

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or